Sections
| Title | Starting Page | Number of Pages |
|---|
| Table of Contents | 2 | 10 |
| List of Tables | 6 | 3 |
| List of Figures | 9 | 3 |
| Pharmaceuticals &Healthcare, Global, Deal Summary | 12 | 8 |
| Pharmaceuticals &Healthcare, Global, Deal Analysis, August 2016 | 12 | 2 |
| Pharmaceuticals &Healthcare, Global, Major Deals, August 2016 | 14 | 1 |
| Pfizer to Acquire Medivation in Tender Offer | 14 | 1 |
| Samsung Biologics Files Registration Statement for IPO for up to USD2.7 Billion | 15 | 1 |
| BioMarin Pharma Prices Public Offering of Shares for USD720 Million | 16 | 1 |
| Pfizer Acquires Bamboo Therapeutics | 16 | 1 |
| Sunovion Pharma to Acquire Cynapsus Therapeutics for Approximately USD624 Million | 16 | 2 |
| Pharmaceuticals &Healthcare, Global, by Type, Number of Deals, August 2016 | 18 | 1 |
| Pharmaceuticals &Healthcare, Global, by Type, Deal Values, August 2016 | 19 | 1 |
| Pharmaceuticals and Healthcare, Global, Deals, Summary, by Type | 20 | 25 |
| Pharmaceuticals &Healthcare, Global, M&A, August 2016 | 20 | 1 |
| Top M&A Deals in August 2016 | 21 | 1 |
| Pharmaceuticals &Healthcare, Global, M&A Deals by Therapy Area, March 2016 August 2016 | 22 | 1 |
| Pharmaceuticals &Healthcare, Global, Equity Offering Deals, August 2016 | 23 | 1 |
| Top Equity Offering Deals in August 2016 | 24 | 1 |
| Pharmaceuticals &Healthcare, Global, Equity Offering Deals by Therapy Area, March 2016 August 2016 | 25 | 1 |
| Pharmaceuticals &Healthcare, Global, Private Equity and Venture Capital Deals, August 2016 | 26 | 1 |
| Top PE/VC Deals in August 2016 | 27 | 1 |
| Pharmaceuticals &Healthcare, Global, PE/VC by Therapy Area, August 2016 | 28 | 1 |
| Pharmaceuticals &Healthcare, Global, Venture Capital Deals by Stage of Financing, August 2016 | 29 | 2 |
| Pharmaceuticals &Healthcare, Global, Top Venture Financing Firms, March 2016 August 2016 | 31 | 1 |
| Pharmaceuticals &Healthcare, Global, Top VC Backed Companies, March 2016 August 2016 | 32 | 1 |
| Pharmaceuticals &Healthcare, Global, Partnership Deals, August 2016 | 33 | 2 |
| Pharmaceuticals &Healthcare, Global, Partnership Deals by Therapy Area, March 2016 August 2016 | 35 | 1 |
| Pharmaceuticals &Healthcare, Global, Partnership Deals by Upfront and Milestone Payments and Deal Values (US$ m), August 2016 | 36 | 1 |
| Pharmaceuticals &Healthcare, Global, Top Partnership Deals by Payment Mode, August 2016 | 37 | 1 |
| Pharmaceuticals &Healthcare, Global, Partnership Deals by Therapy Area, by Upfront and Milestone Payments and Deal Values (US$ m), March 2016 August 2016 | 38 | 2 |
| Pharmaceuticals &Healthcare, Global, Partnership Deals by Phase, Number Of Deals, March 2016 August 2016 | 40 | 1 |
| Pharmaceuticals &Healthcare, Global, Partnership Deals by Phase, Deal Values (US$ m), March 2016 August 2016 | 41 | 2 |
| Pharmaceuticals &Healthcare, Global, Partnership Deals by Phase, by Upfront &Milestone Payments and Deal Values (US$ m), March 2016 August 2016 | 43 | 2 |
| Pharmaceuticals &Healthcare, Global, Licensing Agreements, August 2016 | 45 | 12 |
| Pharmaceuticals &Healthcare, Global, Licensing Agreements, August 2016 | 45 | 2 |
| Pharmaceuticals &Healthcare, Global, Licensing Agreement Deals, Upfront and Milestone Payments and Deal Values (US$ m), August 2016 | 47 | 2 |
| Pharmaceuticals &Healthcare, Global, Licensing Agreement Deals by Therapy Area, Total Deal Values (US$ m), March 2016 August 2016 | 49 | 2 |
| Pharmaceuticals &Healthcare, Global, Licensing Agreement Deals by Therapy Area, Upfront Payments and Milestone Payments (US$ m), March 2016 August 2016 | 51 | 1 |
| Pharmaceuticals &Healthcare, Global, Licensing Agreement Deals by Phase, Total Deal Values (US$ m), March 2016 August 2016 | 52 | 2 |
| Pharmaceuticals &Healthcare, Global, Licensing Agreement Deals by Phase, Upfront Payments and Milestone Payments (US$ m), March 2016 August 2016 | 54 | 1 |
| Pharmaceuticals &Healthcare, Global, Top Licensing Agreements by Deal Value, August 2016 | 55 | 1 |
| Pharmaceuticals &Healthcare, Global, Top Licensing Agreements, by Total Upfront Payments, August 2016 | 56 | 1 |
| Pharmaceuticals &Healthcare, Global, Top Licensing Agreements by Total Milestone Payment, August 2016 | 56 | 1 |
| Pharmaceuticals &Healthcare, Global, Deal Summary by Therapy Area | 57 | 19 |
| Pharmaceuticals &Healthcare, Global, Oncology Deals, August 2016 | 57 | 1 |
| Oncology Deals of the Month | 58 | 2 |
| Pharmaceuticals &Healthcare, Global, Central Nervous System Deals, August 2016 | 60 | 1 |
| Central Nervous System Deals of the Month | 61 | 3 |
| Pharmaceuticals &Healthcare, Global, Infectious Disease Deals, August 2016 | 64 | 1 |
| Infectious Diseases Deals of the Month | 65 | 1 |
| Pharmaceuticals &Healthcare, Global, Cardiovascular Deals, August 2016 | 66 | 1 |
| Cardiovascular Deals of the Month | 67 | 1 |
| Pharmaceuticals &Healthcare, Global, Immunology Deals, August 2016 | 68 | 1 |
| Immunology Deals of the Month | 69 | 2 |
| Pharmaceuticals &Healthcare, Global, Dermatology Deals, August 2016 | 71 | 1 |
| Dermatology Deal of the Month | 72 | 2 |
| Pharmaceuticals &Healthcare, Global, Metabolic Disorders, Deals, August 2016 | 74 | 1 |
| Metabolic Disorders Deal of the Month | 75 | 1 |
| Deal Summary by Geography | 76 | 13 |
| Pharmaceuticals &Healthcare, North America Deals, August 2016 | 76 | 1 |
| North America Deals of the Month | 77 | 2 |
| Pharmaceuticals &Healthcare, Europe, Deals, August 2016 | 79 | 1 |
| Europe Deals of the Month | 80 | 3 |
| Pharmaceuticals &Healthcare, Asia-Pacific, Regional Deals, August 2016 | 83 | 1 |
| Asia-Pacific Deals of the Month | 84 | 2 |
| Pharmaceuticals &Healthcare, Rest of the World, Deals, August 2016 | 86 | 1 |
| Rest of the World Deals of the Month | 87 | 2 |
| Pharmaceuticals &Healthcare, Global, Top Financial Advisors | 89 | 4 |
| Pharmaceuticals &Healthcare, Global, Top Financial Advisors, M&A, March 2016 August 2016 | 89 | 2 |
| Pharmaceuticals &Healthcare, Global, Top Financial Advisors, Equity Offerings, March 2016 August 2016 | 91 | 2 |
| Further Information | 93 | 4 |
| Methodology | 93 | 1 |
| About GlobalData | 94 | 1 |
| Disclosure information | 94 | 1 |
| Disclaimer | 95 | 2 |